{"name":"Instil Bio","slug":"instil-bio","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":39604000,"netIncome":-71372000,"cash":6638000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2021"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"date":"2026-04-03","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-27","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQclU2QmVOVVZNcXUwQi1kbTExM1dFMnVwQWFrQ0t5eVh1VW81WEYyUVp3UHhBUTZoUWs3TEtqMUZFQkZzcWZhOHJ3ek1FZVBZV01jOGl0cnpvdlJ2bVd0Y3NWbVZtdFdGZVp2bFRvWWVBeWJQTVBmY2dBNjRhUGQ3bmwwWFppcFJJWDZoYVJiNlpvVlNSSDFoQ3lFbXFKS3QwRVE?oc=5","date":"2026-01-09","type":"deal","source":"Fierce Pharma","summary":"Fierce Pharma Asia—China biotech deal spree rolls on; Shionogi buys Tanabe's ALS business - Fierce Pharma","headline":"Fierce Pharma Asia—China biotech deal spree rolls on; Shionogi buys Tanabe's ALS business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNQ1Vydl9YS25jOUhEVHRLaU1INHZrMDhPU3pDWGJDOW8tVURMMkZoRXdER05ld0NvNGxSQkhYUWdkZEFSaFNiZXRSd2daSC16X3VtcE1tbXgwSnZ1ZW0xejNodlI1OUZoUHlEeU9Na19seHBQSDFfUy1FeTFXaVFNU2Jqejl1XzRoaGtBY0hhaEFTWVJTUzMxWVJKeWg2T2RKLXF0RkhySE5wODhyYWFRT2p1TVAzRzQzNS10MUFYcFNTbVpq?oc=5","date":"2026-01-06","type":"pipeline","source":"Fierce Biotech","summary":"Instil's stock sinks after it clears out pipeline, hands 2 drugs back to ImmuneOnco - Fierce Biotech","headline":"Instil's stock sinks after it clears out pipeline, hands 2 drugs back to ImmuneOnco","sentiment":"neutral"},{"date":"2026-01-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-11-13","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-11-13","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-26","type":"earnings","source":"simplywall.st","summary":"Institutional owners may ignore Instil Bio, Inc.'s (NASDAQ:TIL) recent US$21m market cap decline as longer-term profits stay in the green - simplywall.st","headline":"Institutional owners may ignore Instil Bio, Inc.'s (NASDAQ:TIL) recent US$21m market cap decline as longer-term profits ","sentiment":"negative"},{"date":"2025-08-13","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-08-13","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-07-31","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFBScXRtQ0tnTHAtQ1RNeTQwUm9HcmNXWXVJUzg0NGo4b2dUVnVYSS01ekpBUlpXa1J0bDlpWlhham5ubzhYZXh4dW5yanlVR19ZSnc?oc=5","date":"2025-06-06","type":"trial","source":"Endpoints News","summary":"IPO Tracker (2021) - Endpoints News","headline":"IPO Tracker (2021)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPLVc3ZUY5ZVBKbmhJWlZnZ0YwaDlOb2tiWDk2YVNEdTFSX2h6RDJzT01BMFI4cHRHSEJQenVjVGRSR1IyaDU0V1dDaUdzWlZKYmN0UmR6d1NNcEJtVVN6cmFhY2FCRmI2SU9yRmItTF9TOG1WcXZPMWZnWml0aVZITUdLZngxN1Q4enpUZXI2eFdSQXoyN2dZ?oc=5","date":"2025-06-06","type":"pipeline","source":"Fierce Biotech","summary":"Protara gears up for next commercial steps—Chutes & Ladders - Fierce Biotech","headline":"Protara gears up for next commercial steps—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQbnNRUDI1ZDJ2alU2NzVRUXR3aFNUSm15cF9XVE9DYi1RS1dWZjJBam5YZUtIT2stQkJzMjNQTllMVUs4Y3U2dGlycjN2aUR4WkxxZzFfUnJZUVF3RWE3TE5iRDRIM0taMEUzMVBnb0NVektvZWdMa25nLXdEdUx0ZFZ2TzJPZjNWWEhLXzRmQ1Q4eWYxVGo1RXVPdHlGQQ?oc=5","date":"2025-06-05","type":"pipeline","source":"Dallas Innovates","summary":"Instil Bio Appoints ‘Seasoned’ Biopharma Exec as Chief Medical Officer - Dallas Innovates","headline":"Instil Bio Appoints ‘Seasoned’ Biopharma Exec as Chief Medical Officer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":0,"revenuePeriod":"2021-12-31","revenueHistory":[{"value":0,"period":"2021-12-31"},{"value":138000,"period":"2020-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":39604000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-71372000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":6638000,"cashHistory":[],"totalAssets":203523000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}